Project Grant R21EY035816
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$241K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
The National Eye Institute (NEI) awarded a $623,090 Project Grant (CFDA 93.867 - Vision Research) to Oregon Health & Science University (OHSU) to develop a wide-field visible-light optical coherence tomography (WF-VIS-OCT) device optimized for the rat eye model of oxygen-induced retinopathy (OIR). The goals are to: 1) Build the new WF-VIS-OCT system capable of high-resolution 5-mm field-of-view imaging; 2) Develop deep learning algorithms to quantify retinal capillary vasculature, blood...
The National Eye Institute (NEI) awarded a $256,296 Project Grant (CFDA 93.867 - Vision Research) to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop a new adaptive ranging optical coherence tomography angiography (OCTA) technology. The project aims to expand the imaging depth range of OCTA, which is used to diagnose and monitor eye diseases affecting the retinal microvasculature, such as diabetic retinopathy and macular degeneration. The project...
The National Eye Institute (NEI) awarded a $580,331 Project Grant (CFDA 93.867 - Vision Research) to The Trustees of the Stevens Institute of Technology in Hoboken, New Jersey. This 4-year grant, effective September 1, 2024, aims to develop a deep learning-based diagnostic tool for detecting retinopathy of prematurity (ROP), a leading cause of childhood blindness globally. The key products and services to be delivered under this award include: Optimizing and testing an animal-to-human (A2H)...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) provides $193,168 to Duke University to develop a novel, auto-aligning hand-held optical coherence tomography (OCT) and OCT angiography (OCTA) probe. The objective is to create a system capable of stable and repeatable high-quality retinal structure and angiographic imaging in infants and children, addressing the challenges of consistently acquiring OCT and OCTA data in...
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $881,796 to Siloam Vision, Inc. to develop two advanced, laser-based, AI-enabled retinal imaging systems. The key innovations include: A wider field-of-view camera design that can be paired with either a scanning laser ophthalmoscope (SLO) or optical coherence tomography (OCT) system, offering 2D or 3D imaging of the entire retina without requiring pupil dilation. Super-resolution AI algorithms to...
This Project Grant award from the National Eye Institute (NEI), under the NEI Vision Research federal grant program (CFDA 93.867), provides $673,747 to New York University School of Medicine to develop a visible-to-near-infrared spanning optical coherence tomography (OCT) system. The goal is to image and quantify retinal macular pigments and retinal pigment epithelium melanosomes at up to 0.5 micrometer axial resolution, which is significantly finer than current commercial OCT systems. This...
This $215,454 exploratory/developmental research grant awarded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) seeks to advance diagnostic ophthalmic imaging capabilities. The project aims to develop a robotically-aligned optical coherence tomography (RAOCT) system that can automatically measure a retinal biomarker, outer nuclear layer (ONL) thickness, which is not readily quantifiable using standard OCT devices. The proposed RAOCT system will...
This Project Grant award of $745,607 from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of the RETIVUE ENTIREEYE, a handheld, high-resolution, non-contact retinal screening camera for premature and healthy newborn babies. The RETIVUE ENTIREEYE is designed to overcome limitations of current screening technologies and enable widespread, simplified screening for retinopathy of prematurity (ROP), a leading cause of infant blindness. The 12-month...
The National Eye Institute (NEI) awarded Oregon Health & Science University (OHSU) a $247,800 Project Grant (CFDA 93.867 - Vision Research) to develop novel tools to diagnose and classify uveitis, a common cause of blindness in the United States. The project aims to (1) develop ultrahigh-resolution optical coherence tomography (OCT) imaging capabilities to precisely quantify and classify inflammation in the aqueous and vitreous humor of uveitis patients, and (2) create OCT-based biomarkers...
The National Eye Institute (NEI), part of the National Institutes of Health, awarded a $331,131 Project Grant under the Vision Research program (CFDA 93.867) to Physical Sciences Inc. (PSI) to develop and validate a high-resolution retinal imaging system with light flicker capabilities. This system aims to enable objective characterization of the photoreceptor response to light and quantify differences between normal and diseased eyes, particularly for patients with diabetic retinopathy. PSI,...